A previous study from our team showed that the mRNA expression of IL-17 and IFN-γ was significantly increased in active BD patients [4], and another study showed that cyclosporine A (CsA) can markedly inhibit the production of both IL-17 and IFN-γ in BD patients [7]. This evidence concerns the gene IFNG and Behcet disease.